Armine Smith (@akfsurgeon) 's Twitter Profile
Armine Smith

@akfsurgeon

ID: 619634237

calendar_today27-06-2012 03:23:41

147 Tweet

305 Followers

254 Following

European Urology (@euplatinum) 's Twitter Profile Photo

New Words of Wisdom from Sola Adeleke MBBS, MBA, FRCR, PhD Boris Tocco, and Veeru Kasivisvanathan Re: Chemoradiotherapy in Muscle-invasive Bladder Cancer (BC2001): 10-year Follow-up of a Phase 3 Randomised Controlled Trial buff.ly/3NC8N7g

New Words of Wisdom from <a href="/sola_sesola2003/">Sola Adeleke MBBS, MBA, FRCR, PhD</a> Boris Tocco, and Veeru Kasivisvanathan

Re: Chemoradiotherapy in Muscle-invasive Bladder Cancer (BC2001): 10-year Follow-up of a Phase 3 Randomised Controlled Trial

buff.ly/3NC8N7g
Armine Smith (@akfsurgeon) 's Twitter Profile Photo

Excellent talk by @Svet_MD at #BCANTT22 about organ sparing cystectomy in women and sexual satisfaction. Def more research needed on what's more important: sparing organs or nerves or preop education?

Armine Smith (@akfsurgeon) 's Twitter Profile Photo

Thank you Sima Porten Dr. Bishoy M. Faltas and Bladder Cancer Advocacy Network for putting together a fantastic program at #BCANTT22. It was great seeing everyone in person! Looking forward to another great meeting next year!

YUO (@suo_yuo) 's Twitter Profile Photo

It has been brought to our attention the disgraceful comment from one of our members . We have committed wholeheartedly to teach all our members gender equity is everyone’s fight & responsibility. We WILL continue this uphill battle with 100% support Society of Urologic Oncology leaders SWIU

Armine Smith (@akfsurgeon) 's Twitter Profile Photo

Wonderfully stimulating talks and discussion on variety of topics with our European colleagues at #IBCN2022. So great to see the international community of clinicians and researchers joined together to fight #BladderCancer!

Adam B. Weiner, MD (@adam_weiner535) 's Twitter Profile Photo

Published in NEJM Evidence Blue light turbt does not 📉 recurrence rates for int/high risk #NMIBC and was more costly $$$ 3-yr RFS 56% v 62% for white light (p=0.7) Curious how urologist will respond? YUO Society of Urologic Oncology Link: tinyurl.com/2p8fk9yc

Published in <a href="/NEJMEvidence/">NEJM Evidence</a> 

Blue light turbt does not 📉 recurrence rates for int/high risk #NMIBC and was more costly $$$

3-yr RFS 56% v 62% for white light (p=0.7)

Curious how urologist will respond?

<a href="/SUO_YUO/">YUO</a> <a href="/UroOnc/">Society of Urologic Oncology</a> 

 Link: tinyurl.com/2p8fk9yc
Zeyad Schwen MD (@zschwen) 's Twitter Profile Photo

Terry Bradshaw has been battling #BladderCancer - hope he is doing well. His struggle can bring awareness to #BladderCancer and also hope to those who are facing it Amer. Urol. Assn. Bladder Cancer Advocacy Network Pittsburgh Steelers NFL

Armine Smith (@akfsurgeon) 's Twitter Profile Photo

Thank you Amer. Urol. Assn. and Urology Care Foundation for the opportunity to present on gender discrepancies in bladder cancer at the AUA BHA meeting. Hoping this info can help promote advocacy and better care for our patients with bladder cancer.

Armine Smith (@akfsurgeon) 's Twitter Profile Photo

Had a patient today with complete regression of large volume renal and ureteral tumors after 2 Jelmyto treatments - had to stop early 2/2 allergic rxn. Whether it's the medication or her prayers... 😁👏🏻UroGen Pharma

Sarah P. Psutka MD MS (@spsutkamd) 's Twitter Profile Photo

Calling all #WomenInUroOncology Society of Urologic Oncology YUO! Join us for a high impact #WUO-sponsored Leadership Seminar: 🔥🔥"Trust: The Secret Ingredient to High Performance During Adversity" Nov 16 @ 8p. us02web.zoom.us/meeting/regist… lead by the awesome Natalie A Johnson All #WUO are welcome!

Armine Smith (@akfsurgeon) 's Twitter Profile Photo

Just in time for the interview season: urologist is the most stressful U.S. job, pays $208,000 per year cnbc.com/2022/12/08/uro…

Armine Smith (@akfsurgeon) 's Twitter Profile Photo

A new FDA-approved option is now available for BCG-unresponsive patients. It's truly an exciting time for innovation in bladder cancer care. targetedonc.com/view/fda-appro…

Sarah P. Psutka MD MS (@spsutkamd) 's Twitter Profile Photo

Sure, we can...but *should* we? Thoughtful & objective evaluation of surgical candidacy is a critical surgical skill. Join me, Viraj Master Bernie Bochner, MD & Tullika Garg, MD, MPH on 5/4/24 @ 4p, Rm213 as we delve into the science of risk stratification & perioperative optimization. #AUA2024

Sure, we can...but *should* we? Thoughtful &amp; objective evaluation of surgical candidacy is a critical surgical skill. Join me, <a href="/virajmaster/">Viraj Master</a> <a href="/bbmdmsk/">Bernie Bochner, MD</a> &amp; <a href="/Tullika_Garg/">Tullika Garg, MD, MPH</a> on 5/4/24 @ 4p, Rm213 as we delve into the science of risk stratification &amp; perioperative  optimization. #AUA2024
Armine Smith (@akfsurgeon) 's Twitter Profile Photo

"#bcantt24 Massive potential to improve urology practices! 🚭 Many patients are unaware that smoking cessation is crucial for bladder cancer prevention and treatment. Let's bridge the knowledge gap and make a difference! 💪 #BladderCancer #Urology #PublicHealth"

"#bcantt24 Massive potential to improve urology practices! 🚭 Many patients are unaware that smoking cessation is crucial for bladder cancer prevention and treatment. Let's bridge the knowledge gap and make a difference! 💪 #BladderCancer #Urology #PublicHealth"